Xenetic Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Revenue	2.54	1.71	1.16	0.44	0.02	0	7.59	3	0	0	Upgrade
Revenue Growth (YoY)	48.80%	47.06%	165.64%	2460.31%	-	-	152.83%	-	-	-	Upgrade
Cost of Revenue	0	0	0	0	0	0	0.16	0	0	0	Upgrade
Gross Profit	2.54	1.71	1.16	0.44	0.02	0	7.43	3	0	0	Upgrade
Selling, General & Admin	3.56	3.65	3.74	3.4	4.73	4.39	6.94	6.69	6.39	6.6	Upgrade
Research & Development	3.49	4.77	3.16	1.73	4.89	2.88	4.06	43.74	3.43	6.32	Upgrade
Other Operating Expenses	0	0	0	9.24	3.28	0	0	0	0	0	Upgrade
Operating Expenses	7.06	8.42	6.91	14.37	12.9	7.28	11	50.43	9.82	12.92	Upgrade
Operating Income	-4.52	-6.72	-5.75	-13.94	-12.89	-7.28	-3.57	-47.43	-9.82	-12.92	Upgrade
Interest Expense / Income	0	0	0	0	0	0	0	0.73	0.27	0	Upgrade
Other Expense / Income	-0.38	-0.17	-0.1	-0.13	-0.11	0.02	0.02	6.05	2.42	1.38	Upgrade
Pretax Income	-4.13	-6.55	-5.65	-13.81	-12.78	-7.3	-3.6	-54.21	-12.51	-14.31	Upgrade
Income Tax	0	0	0	-2.92	0	0	0	0	0	0	Upgrade
Net Income	-4.13	-6.55	-5.65	-10.89	-12.78	-7.3	-3.6	-54.21	-12.51	-14.31	Upgrade
Preferred Dividends	0	0	0	0	5.28	0	0	4.04	0	0	Upgrade
Net Income Common	-4.13	-6.55	-5.65	-10.89	-18.06	-7.3	-3.6	-58.24	-12.51	-14.31	Upgrade
Shares Outstanding (Basic)	2	1	1	1	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	2	1	1	1	0	0	0	0	0	0	Upgrade
Shares Change	7.44%	38.38%	60.81%	124.10%	277.30%	4.69%	16.62%	75.92%	2.58%	13.40%	Upgrade
EPS (Basic)	-2.71	-4.61	-5.50	-17.00	-63.30	-96.60	-49.80	-940.80	-355.20	-435.64	Upgrade
EPS (Diluted)	-2.71	-4.61	-5.50	-17.00	-63.30	-96.60	-49.80	-940.80	-355.20	-435.64	Upgrade
Free Cash Flow	-4.11	-4.65	-4.74	-4.27	-6.4	-6.44	1.48	-8.8	-5.29	-12.74	Upgrade
Free Cash Flow Per Share	-2.69	-3.27	-4.61	-6.67	-22.43	-85.20	20.56	-142.18	-150.42	-371.14	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	-	97.94%	100.00%	-	-	Upgrade
Operating Margin	-177.79%	-393.57%	-495.12%	-3189.82%	-75511.71%	-	-47.05%	-1581.02%	-	-	Upgrade
Profit Margin	-162.78%	-383.87%	-486.36%	-2493.11%	-105820.95%	-	-47.40%	-1941.38%	-	-	Upgrade
Free Cash Flow Margin	-161.98%	-272.23%	-408.21%	-976.60%	-37486.25%	-	19.58%	-293.47%	-	-	Upgrade
EBITDA	-4.13	-6.53	-5.61	-13.78	-12.75	-7.28	-3.57	-53.44	-12.18	-14.21	Upgrade
EBITDA Margin	-162.78%	-382.28%	-483.31%	-3154.46%	-74695.52%	-	-47.06%	-1781.34%	-	-	Upgrade
Depreciation & Amortization	0	0.03	0.04	0.03	0.03	0.02	0.02	0.04	0.06	0.09	Upgrade
EBIT	-4.13	-6.55	-5.65	-13.81	-12.78	-7.3	-3.59	-53.48	-12.24	-14.3	Upgrade
EBIT Margin	-162.78%	-383.87%	-486.36%	-3161.06%	-74856.59%	-	-47.37%	-1782.55%	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).